26-week dreams trial of a selective s1p receptor agonist ono-4641 in patients with relapsing-remitting multiple sclerosis

Authors
Category Primary study
ConferenceNeurology
Year 2012
This article has no abstract
Epistemonikos ID: 6a3289dce2465c2549d8ec65de59bb3accafc341
First added on: Apr 30, 2026